<DOC>
	<DOCNO>NCT01684189</DOCNO>
	<brief_summary>Objectives： 1 . To assess percentage febrile neutropenia suspect fungal-related febrile episode patient receive chemotherapy 2 . To explore percentage/distribution infectious origin febrile neutropenia 3 . To explore percentage/distribution infectious pathogen febrile neutropenia 4 . To explore clinical outcome different infectious origins/pathogens febrile neutropenia episodes 5 . To clear view therapeutic action management hematological patient febrile neutropenia suspect fungal-related febrile episode</brief_summary>
	<brief_title>Registry Febrile Neutropenia Invasive Fungal Infections</brief_title>
	<detailed_description>Objectives： 1 . To assess percentage febrile neutropenia suspect fungal-related febrile episode patient receive chemotherapy 2 . To explore percentage/distribution infectious origin febrile neutropenia 3 . To explore percentage/distribution infectious pathogen febrile neutropenia 4 . To explore clinical outcome different infectious origins/pathogens febrile neutropenia episodes 5 . To clear view therapeutic action management hematological patient febrile neutropenia suspect fungal-related febrile episode Study Design： - This single institute , prospective , non-interventional registry monitoring event febrile neutropenia hematological patient - Patients newly diagnose malignant hematological disease enrol registry Study Procedures： Data collection include patient ' basic information , underlie disease , baseline blood chemistry blood cell count , antifungal prophylaxis , C/T regimens , neutrophil blood cell , fever diagnosis infectious sit work-up , clinical response , microbiology ( include bacteria fungus culture ) , renal liver function , clinical diagnosis , work-up intensive procedure result , antifungal antibacterial agent ( include dosage , duration , route ) , drug use ( include antiviral , antineoplastic , corticosteroid , immunomodulators ) , clinical significant change Sample Size Calculation Statistical Analysis： Approximately 100 febrile neutropenia episodes 500 chemotherapy cycle collect . This observational exploratory study without hypothesis test . Study subject collect monitored normal clinical practice , sample size limit due hospital scale disease characteristic ( sample size calculation inapplicable ) . All evaluation show exploratory descriptive data analysis . The number case investigative definition , correspond percentage 95 % confidence interval describe .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Febrile Neutropenia</mesh_term>
	<mesh_term>Hematologic Diseases</mesh_term>
	<criteria>Patients new diagnosed hematological disease ( acute chronic myeloid lymphoid leukemia , multiple myeloma , nonHodgkin 's Hodgkin 's lymphoma , myelodysplastic syndrome ) Patients receive chemotherapy ongoing febrile episode</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>